Skip to main content
. 2022 Nov 23;12:1052628. doi: 10.3389/fonc.2022.1052628

Table 2.

Comparisons of the overall and severe complications between the groups.

    Overall complications, N=123 (%) P value Severe complications, N=26 (%) P value
BMI (kg/m2) <0.001 0.927
 <24 308 72 (23.38) 19 (6.17)
 ≥24 118 51 (43.22) 7 (5.93)
mFI <0.001 <0.001*
 0-1 358 84 (23.46) 14 (3.91)
 2-4 68 39 (57.35) 12 (17.65)
FIGO stage 0.001 0.016*
 IIIC 379 100 (26.39) 19 (5.01)
 IV 47 23 (48.94) 7 (14.89)
Surgery timing 0.025 0.013
 PDS 179 62 (34.64) 17 (9.50)
 IDS 247 61 (24.70) 9 (3.64)
SCS 0.009 0.027
 low 85 25 (29.41) 4 (4.71)
 intermediate 284 72 (25.35) 14 (4.93)
 High 57 26 (45.61) 8 (14.04)
Operative time (minutes) <0.001 0.027
 <300 204 43 (21.08) 7 (3.43)
 ≥300 222 80 (36.04) 19 (8.56)
Intraoperative blood loss (ml) <0.001 0.002
 <500 171 33 (19.30) 3 (1.75)
 ≥500 255 90 (35.29) 23 (9.02)
Postoperative hospital stay(days) <0.001 <0.001
 <9 186 9 (4.84) 2 (1.08)
 ≥9 240 114 (47.50) 24 (10.00)
Adjuvant chemotherapy 0.267 0.258
 Yes, started within 42 days 367 102 (27.79) 21 (5.72)
 No, or started after 42 days 51 18 (35.29) 5 (9.80)

*fisher test.